Press Releases

04-12-2009 (Ad hoc press release)

Eckert & Ziegler: capital increase successfully concluded / clear oversubscription

03-12-2009 (Ad hoc press release)

Eckert & Ziegler: Re-Enter the U.S Market with Therapeutic Products

24-11-2009

Eckert & Ziegler winner of "Selected Landmarks in the Land of Ideas 2010"

13-11-2009 (Ad hoc press release)

Eckert & Ziegler: Strike price for capital increase at 15.95 EUR per share and other details of the capital increase also fixed

10-11-2009 (Ad hoc press release)

Eckert & Ziegler resolves capital increase

03-11-2009

Eckert & Ziegler: Record sales and a strong capital flow

21-10-2009

Eckert & Ziegler commissioned to produce an innovative cancer medication

14-10-2009

Eckert & Ziegler awards grants to young researchers in nuclear medicine

06-10-2009

Eckert & Ziegler: Choosing the IBt Bebig Temporary Brachytherapy solution MultiSource® HDR Co-60 afterloader

30-09-2009

Eckert & Ziegler: Shares from the capital increase of February 2009 authorised for trading (Prime Standard)

04-08-2009

Eckert & Ziegler continues on record course. Strongest half year in company history.

20-07-2009 (Ad hoc press release)

Eckert & Ziegler achieves best six-month result and raises profit forecast

10-07-2009

Eckert & Ziegler: 1,000th patient Treated with I-125 implants at Christie Hospital, Manchester - England

02-07-2009

Hearings on IBt Take-over Bid Case Moved up to November

23-06-2009

Eckert & Ziegler's associated company IBt Bebig signs contracts about a joint venture in the Russian Federation

29-05-2009

Eckert & Ziegler: Stock Buy Back Programme Approved

29-05-2009 (Ad hoc press release)

Eckert & Ziegler appeals against CBFA decision

05-05-2009

Eckert & Ziegler: New Heights in Revenues and Profits in Q 1 2009

28-04-2009 (Ad hoc press release)

Belgian Securities Regulator Requires Take-over Bid but Suspends Action

09-04-2009

IBt and Russian state fund set up joint venture to manufacture prostate cancer implants in Russia